Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Radu

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoireEvan R Abt, Alex K Lam, Miyako Noguchi, et al.
Cell Reports|January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cellsEvan R Abt, Thuc M Le, Amanda M Dann, et al.
Cancer Discovery|December 6, 2022
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic CancerSamantha B Kemp, Noah Cheng, Nune Markosyan, et al.
Journal of Medicinal Chemistry|August 17, 2013
Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomographyJennifer M Murphy, Amanda L Armijo, Julian Nomme, et al.
The Journal of Clinical Investigation|June 2, 2022
Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunityEvan R Abt, Khalid Rashid, Thuc M Le, et al.
RSC Medicinal Chemistry|January 22, 2021
Isoquinoline thiosemicarbazone displays potent anticancer activity with <i>in vivo</i> efficacy against aggressive leukemiasDaniel L Sun, Soumya Poddar, Roy D Pan, et al.
The Journal of Experimental Medicine|February 26, 2014
Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradicationDavid A Nathanson, Amanda L Armijo, Michelle Tom, et al.
Nature Communications|January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trialZev A Wainberg, Jason M Link, Alykhan Premji, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activityWoosuk Kim, Thuc M Le, Liu Wei, et al.
The Journal of Clinical Investigation|November 23, 2021
Cardiomyocytes disrupt pyrimidine biosynthesis in nonmyocytes to regulate heart repairShen Li, Tomohiro Yokota, Ping Wang, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoireEvan R Abt, Alex K Lam, Miyako Noguchi, et al.
Cell Reports|January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cellsEvan R Abt, Thuc M Le, Amanda M Dann, et al.
Cancer Discovery|December 6, 2022
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic CancerSamantha B Kemp, Noah Cheng, Nune Markosyan, et al.
Journal of Medicinal Chemistry|August 17, 2013
Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomographyJennifer M Murphy, Amanda L Armijo, Julian Nomme, et al.
The Journal of Clinical Investigation|June 2, 2022
Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunityEvan R Abt, Khalid Rashid, Thuc M Le, et al.
RSC Medicinal Chemistry|January 22, 2021
Isoquinoline thiosemicarbazone displays potent anticancer activity with <i>in vivo</i> efficacy against aggressive leukemiasDaniel L Sun, Soumya Poddar, Roy D Pan, et al.
The Journal of Experimental Medicine|February 26, 2014
Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradicationDavid A Nathanson, Amanda L Armijo, Michelle Tom, et al.
Nature Communications|January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trialZev A Wainberg, Jason M Link, Alykhan Premji, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activityWoosuk Kim, Thuc M Le, Liu Wei, et al.
The Journal of Clinical Investigation|November 23, 2021
Cardiomyocytes disrupt pyrimidine biosynthesis in nonmyocytes to regulate heart repairShen Li, Tomohiro Yokota, Ping Wang, et al.
Pageof 12